In the present study, we first make a critical advancement by synthesizing a novel nanodrug, F127ZIF‐8AB680, which not only targets CD73 and reduces adenosine production but also exhibits enhanced stability, bioavailability, and tumor‐targeting properties. Here, NT5E is linked to neoplasm.